Osteoporosis in Post-menopausal Women
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
HELP TherapeuticsChina - Nanjing
1 programHuman Umbilical Cord-derived Mesenchymal stem cellPHASE_11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
HELP TherapeuticsHuman Umbilical Cord-derived Mesenchymal stem cell
Clinical Trials (1)
Total enrollment: 9 patients across 1 trials
Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture
Start: Jun 2025Est. completion: Sep 20269 patients
Phase 1Active Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.